LAS VEGAS, March 27, 2018 /PRNewswire/ -- Today at
Medtrade Spring in Las Vegas,
Nevada (March 27-29),
Royal Philips (NYSE: PHG, AEX:
PHIA), a global leader in health technology, announced the launch
of DreamWear Full face, the third mask option available for its
award-winning DreamWear mask system. Philips Respironics, the
number one choice brand of U.S. sleep physicians for continuous
positive airway pressure (CPAP) and masks, used the company's
proprietary design tools to analyze facial data from thousands of
3D scans to create a design that prevents red marks, discomfort,
and irritation on the nose bridge.
According to a recent Philips survey [1], U.S. sleep apnea
patients say the top challenges to using CPAP therapy are that the
mask can leave red marks on the face (40 percent) and the hose gets
in the way (42 percent). Additionally, 35 percent of U.S. patients
say traditional masks limit their range of motion, and on a global
level, three in five respondents (63 percent) said they noticed
they had a tendency to breathe through their mouth before being
tested for sleep apnea. Recognizing the challenges sleep apnea
patients face when choosing sleep therapy, Philips aims to help
patients experience the most comfortable night's sleep
possible.
"We've found that patients' acceptance and adherence to PAP
therapy for sleep apnea are very much rooted in selecting a
properly-fitting, effective and comfortable mask," said Dr.
Teofilo Lee-Chiong, chief medical
liaison at Philips. "Our recent survey highlights the challenges
that therapy users are experiencing all over the world and
validates the work Philips has been doing to help them to improve
their quality of life."
The new DreamWear Full face mask was designed to expand on
current Dream Family offerings, with the goal of providing a better
option for sleep apnea patients who breathe through their mouths.
Philips DreamWear Full face features include:
- Comfort: To help combat the challenges that come
with wearing a CPAP mask, Philips designed the new DreamWear Full
face mask that patients say comes closest to feeling like there's
nothing on the face. Users rate the DreamWear Full face mask more
comfortable and less intimidating than their prescribed mask [2].
Its innovative design helps to prevent red marks, discomfort or
irritation on the nose bridge as the cushion is designed to sit
under the nose, not on it.
- Convenience: The new full face cushion is one of
three available for the DreamWear mask system, which directs
airflow through the frame and removes the hose from the front of
the face, giving patients more freedom to sleep comfortably in any
position they desire. The offering also provides an option for
patients when they can no longer breathe through their nose from
allergies or a cold. Additionally, the third cushion option
provides cash-pay opportunities for DMEs and additional mask
options for patients to help offer them the best chance of
long-term therapy success.
- Quality: The DreamWear Full face mask was built
with a thorough understanding of facial geometries and a suite of
proprietary design tools and processes to provide patients with
clinically proven fit, comfort and seal.
Philips at Medtrade Spring
The DreamWear Full face
cushion is the latest addition to Philips' Dream Family of sleep
apnea products focused on connecting and supporting the patient,
clinician and homecare provider to enhance patient care and quality
of life. For more information, visit Philips at booth #613 at
Medtrade Spring, March 27-29, 2018 at
the Mandalay Bay Convention Center in Las
Vegas. Other Philips products on display at the show
highlight the company's innovation in sleep therapy and respiratory
care.
For more on Philips' advanced solutions for sleep and
respiratory care, follow @PhilipsResp or
www.philips.com.
[1] Survey conducted online by Regina Corso
Consulting on behalf of Philips from January
15-22, among 2,000 adults in the U.S., Australia, France, Germany and Canada, all of who have sleep apnea and use a
CPAP machine. For complete survey methodology, please contact
Meredith Amoroso at
meredith.amoroso@philips.com.
[2] Data analysis of Aug
2017 Patient Preference trial where n = 85 and prescribed
masks include Resmed Airfit FlO and F20, Respironics Amara View and
F&P Simplus; based on 10 days of use.
For further information, please contact:
Kathy O'Reilly
Philips Group Press Office
Office: +1 978-659-2638
E-mail: kathy.oreilly@philips.com
Meredith Amoroso
Philips Sleep and Respiratory Care
Mobile: +1 724-584-8991
E-mail: meredith.amoroso@philips.com
About Royal
Philips
Royal Philips
(NYSE: PHG, AEX: PHIA) is a leading health technology company
focused on improving people's health and enabling better outcomes
across the health continuum from healthy living and prevention, to
diagnosis, treatment and home care. Philips leverages advanced
technology and deep clinical and consumer insights to deliver
integrated solutions. Headquartered in the Netherlands, the company is a leader in
diagnostic imaging, image-guided therapy, patient monitoring and
health informatics, as well as in consumer health and home care.
Philips' health technology portfolio generated 2017 sales of
EUR 17.8 billion and employs
approximately 74,000 employees with sales and services in more than
100 countries. News about Philips can be found at
www.philips.com/newscenter.
View original content with
multimedia:http://www.prnewswire.com/news-releases/philips-continues-to-change-the-face-of-sleep-apnea-with-latest-addition-to-the-dreamwear-family-300620011.html
SOURCE Royal Philips